Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77051-77100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05065736
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
EARLY_PHASE1Recruiting
4 participants
Started: Mar 6, 2023 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05523635
Post Market Clinical Evaluation of Gamma 4
N/AActive, not recruiting
100 participants
Started: Mar 6, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor5 locations
NCT05531786
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
PHASE1/PHASE2Recruiting
50 participants
Started: Mar 6, 2023 · Completed: Jul 22, 2027
1 condition1 sponsor2 locations
NCT06641401
Endoscopic FHL Transfer for Acute Achilles Tendon Rupture
N/AEnrolling by invitation
28 participants
Started: Mar 5, 2023 · Completed: Dec 30, 2025
4 conditions2 sponsors1 location
NCT06114368
Endoscopic Flexor Hallucis Longus Transfer vs Minimally Invasive Repair in Acute Achilles Tendon Rupture
N/AEnrolling by invitation
40 participants
Started: Mar 5, 2023 · Completed: Mar 30, 2026
3 conditions3 sponsors1 location
NCT05801848
Diagnosis of Bone Metabolism in Patients With Inexplicable Lower Back Pain
N/AActive, not recruiting
50 participants
Started: Mar 5, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05362097
Analysis of the Reliability and Validity of the Chinese Version of CC-QoL
N/ARecruiting
180 participants
Started: Mar 5, 2023 · Completed: May 5, 2026
1 condition1 sponsor1 location
NCT05604222
Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
PHASE4Recruiting
120 participants
Started: Mar 5, 2023 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT06419556
Analgesic Efficacy of an Intermediate CPB in Neck Surgeries.
NARecruiting
54 participants
Started: Mar 5, 2023 · Completed: Jun 1, 2024
4 conditions1 sponsor1 location
NCT05801185
Single Nuclei Sequencing in Human Skeletal Muscle After Unloading
NAEnrolling by invitation
10 participants
Started: Mar 5, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05792527
L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis
PHASE3Recruiting
46 participants
Started: Mar 5, 2023 · Completed: Mar 5, 2026
1 condition1 sponsor1 location
NCT05714384
Outcome of Calcium Silicate Sealer-based Obturation in Root Canal Retreatment
N/AEnrolling by invitation
126 participants
Started: Mar 5, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06273215
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
PHASE4Recruiting
48 participants
Started: Mar 5, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05717075
Effects of Parents Included in Medical Round of Neonatal Intensive Care Unit
NARecruiting
46 participants
Started: Mar 5, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06252194
Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.
PHASE2Recruiting
120 participants
Started: Mar 5, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT06314334
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
PHASE2Recruiting
210 participants
Started: Mar 4, 2023 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT05750264
Intravenous Ibuprofen Postoperative Analgesia After Abdominal Hysterectomy
PHASE2Active, not recruiting
152 participants
Started: Mar 4, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05512910
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
PHASE4Active, not recruiting
90 participants
Started: Mar 4, 2023 · Completed: Jun 4, 2025
4 conditions6 sponsors1 location
NCT06298071
A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
PHASE1Recruiting
36 participants
Started: Mar 3, 2023 · Completed: Dec 30, 2025
1 condition4 sponsors1 location
NCT05753722
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
PHASE1Recruiting
270 participants
Started: Mar 3, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor9 locations
NCT05768919
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 3, 2023 · Completed: May 31, 2027
1 condition2 sponsors2 locations
NCT05640336
Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression
NAEnrolling by invitation
490 participants
Started: Mar 3, 2023 · Completed: Mar 31, 2032
1 condition1 sponsor2 locations
NCT05754307
A Closed Surgical Technique vs Papilla Preservation Techniques
NARecruiting
44 participants
Started: Mar 3, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05597735
Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease
PHASE3Recruiting
480 participants
Started: Mar 3, 2023 · Completed: Nov 30, 2026
2 conditions4 sponsors12 locations
NCT05711173
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
NARecruiting
150 participants
Started: Mar 3, 2023 · Completed: Mar 31, 2027
4 conditions1 sponsor7 locations
NCT05501899
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
EARLY_PHASE1Recruiting
20 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2024
2 conditions2 sponsors2 locations
NCT05408845
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
PHASE2Recruiting
146 participants
Started: Mar 3, 2023 · Completed: Jul 31, 2028
5 conditions2 sponsors132 locations
NCT05712746
Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure.
N/ARecruiting
1,600 participants
Started: Mar 3, 2023 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06306248
Immune Activation, Neural Plasticity and Depression
N/ARecruiting
60 participants
Started: Mar 3, 2023 · Completed: May 9, 2025
3 conditions1 sponsor1 location
NCT07162051
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
PHASE2Recruiting
28 participants
Started: Mar 3, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05598320
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia
PHASE2/PHASE3Active, not recruiting
84 participants
Started: Mar 3, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor10 locations
NCT05691478
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
PHASE2/PHASE3Recruiting
1,122 participants
Started: Mar 3, 2023 · Completed: Mar 20, 2030
4 conditions1 sponsor156 locations
NCT05640102
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
N/ARecruiting
111 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor11 locations
NCT05699564
Akershus Cardiac Examination 4 Study
NAActive, not recruiting
574 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2038
2 conditions2 sponsors1 location
NCT05737797
Non-Invasive Diagnosis of Endometrial Cancer
NARecruiting
100 participants
Started: Mar 3, 2023 · Completed: Oct 10, 2024
1 condition1 sponsor1 location
NCT06375057
Relationship Between Acute Phase Markers and Post-operative Pain in Laparoscopic Cholecystectomy: An Observational Study
N/ARecruiting
54 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05654623
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
PHASE3Active, not recruiting
624 participants
Started: Mar 3, 2023 · Completed: May 15, 2028
1 condition2 sponsors312 locations
NCT05322954
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
PHASE1Active, not recruiting
12 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT05808699
Camera Qualification Study
N/AActive, not recruiting
626 participants
Started: Mar 3, 2023 · Completed: Jan 30, 2025
1 condition2 sponsors9 locations
NCT05567185
A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer
PHASE1Active, not recruiting
5 participants
Started: Mar 3, 2023 · Completed: Sep 24, 2027
2 conditions1 sponsor4 locations
NCT06416995
Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes
N/ARecruiting
88 participants
Started: Mar 3, 2023 · Completed: Dec 30, 2024
5 conditions1 sponsor1 location
NCT06291675
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
N/ARecruiting
50 participants
Started: Mar 3, 2023 · Completed: Mar 3, 2033
2 conditions1 sponsor1 location
NCT05503173
Telehealth for Pain and Unhealthy Drinking Among PLWH
NARecruiting
385 participants
Started: Mar 3, 2023 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT05676034
AMX0035 in Adult Patients With Wolfram Syndrome
PHASE2Active, not recruiting
12 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06519500
Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery
N/ARecruiting
40 participants
Started: Mar 3, 2023 · Completed: Nov 3, 2026
1 condition1 sponsor1 location
NCT06301282
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
N/ARecruiting
30 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05586074
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
PHASE3Recruiting
324 participants
Started: Mar 3, 2023 · Completed: Jun 14, 2027
1 condition1 sponsor1 location
NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
N/ARecruiting
100 participants
Started: Mar 3, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05556824
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
PHASE2Recruiting
247 participants
Started: Mar 3, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors17 locations
NCT05517928
A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis
NARecruiting
30 participants
Started: Mar 3, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location